Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 1/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 2/20 | 0.50 |
| ▸ | HRH1 | P35367 | 2/20 | 0.50 |
| ▸ | HTR1B | P28222 | 2/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.44 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.44 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.42 |
| ▸ | HTR1D | P28221 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18730913 | 0.93 | ALDH1A1 (0.67) | ALDH1A1MAPTL3MBTL1MEN1KMT2A | |
| SCHEMBL2065279 | 0.88 | ALDH1A1 (1.00) | ALDH1A1MAPTL3MBTL1TSHRHRH3 | |
| SCHEMBL1354067 | 0.86 | MAPT (0.61) | ALDH1A1MAPTL3MBTL1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL3634998 | 0.85 | ALDH1A1 (0.94) | ALDH1A1MAPTL3MBTL1HRH3 | |
| Hydrochloric Acid SCHEMBL25404814 | 0.84 | MAPT (0.58) | ALDH1A1MAPTL3MBTL1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL29727944 | 0.83 | ALDH1A1 (0.90) | ALDH1A1MAPTL3MBTL1HRH3 | |
| SCHEMBL4970157 | 0.83 | ALDH1A1 (0.89) | ALDH1A1MAPTL3MBTL1HRH3 | |
| SCHEMBL5139921 | 0.81 | ALDH1A1 (0.85) | ALDH1A1MAPTL3MBTL1SIGMAR1 | |
| SCHEMBL6439421 | 0.80 | MAPT (0.50) | ALDH1A1MAPTL3MBTL1MEN1KMT2A | |
| SCHEMBL11759173 | 0.80 | ALDH1A1 (0.84) | ALDH1A1MAPTL3MBTL1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118978525-A | Light-activated labeled RNA photosensitizer based on phenothiazine, and preparation method and application thereof | 大连理工大学宁波研究院 | 2024-11-19 | — | — | CN | claimed |
| CN-118978525-A | Light-activated labeled RNA photosensitizer based on phenothiazine, and preparation method and application thereof | 大连理工大学宁波研究院 | 2024-11-19 | — | — | CN | disclosed |
| US-20060025460-A1 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | INFINITY PHARMACEUTICALS, INC. (US) | 2006-02-02 | — | — | US | disclosed |
| US-6348595-B1 | PERYLENE-3,4,9,10-TETRACARBOXIMIDE IS HYDROXYMETHYLATED BY REACTION WITH FORMALDEHYDE TO FORM BIS(HYDROXYMETHYL) PERYLENE-3,4,9,10-TETRACARBOXIMIDE; ONE POT PROCESS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060025460-A1 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | BCL3, BCL2, BCLAF1 | ALDH1A1 3755/4885MAPT 3860/4885L3MBTL1 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.